2017-11-29 Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.
2017-11-28 Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fourth Facility
2017-11-21 Emerald Health Therapeutics Completes Investment in Licensed Dealer Northern Vine
2017-11-20 Emerald Health Therapeutics Appoints Robert C. Hill, CPA, CA as Chief Financial Officer and Promotes Cheryl Evans, CPA, CA to Vice President Finance
2017-11-13 Emerald Health Therapeutics Announces Positive Health Canada Review of its Licensed Producer Application for Pure Sunfarms Facility
2017-11-02 Emerald Health Therapeutics Engages Investor Relations Consultant and Grants Stock Options
2017-10-26 Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine
2017-10-18 Emerald Health’s Two Cannabis Production Expansion Sites Progressing for Legalized Adult-Use Market in 2018
2017-10-02 Emerald Health Therapeutics Appoints Pharmaceutical Marketing and Biotech Executive Chris Wagner as CEO
2017-09-20 Emerald Health Therapeutics’ Scientific Advisors Publish Research Discovery of THCA Cannabinoid’s Neuroprotective Treatment Potential
2017-09-19 Emerald Health Therapeutics Expands its Cannabis Supply with Purchase from Supreme Pharmaceuticals
2017-09-18 Emerald Health Therapeutics Launches Island Mist, One of Canada’s Highest CBD and CBD to THC Ratio Dried Flower Products
2017-09-06 Emerald Health Therapeutics to Present at Rodman & Renshaw Investment Conference
2017-07-18 Emerald Health Files Amended and Restated Final Base Shelf Prospectus
2017-07-10 Emerald Health Announces New U.S. Trading Symbol
2017-07-06 Emerald Health Provides Corporate Update
2017-06-14 Emerald Health Therapeutics Announces Advisory Board; Plans Clinical Research
2017-06-12 Emerald Health Therapeutics Begins Trading on the OTCQX Best Market
2017-06-06 Emerald Health and Village Farms Announce Strategic Venture to Leverage Large-Scale Greenhouse Infrastructure and Cannabis Production Expertise
2017-04-21 Emerald Announces Partial Exercise of Over-Allotment Option in Connection with Recent $24.4 Million Bought-Deal
2017-04-20 Emerald Announces Closing of $24.4 Million Bought Deal
2017-04-17 Emerald Launches Market Leading CBD Oil and Supports Proposed Cannabis Legislation
2017-04-11 Emerald Health Announces Increase in Bought Deal to $24.4 Million
2017-04-10 Emerald Health Announces $17.5 Million Bought Deal
2017-04-05 Emerald Announces Inclusion in the Industry’s First ETF
2017-02-23 Emerald Chosen as Top 50 TSX Venture Winner for 2017
2017-02-22 Emerald Provides Corporate Update & Lays Out 2017 Growth Initiatives
2017-02-10 Emerald Announces Closing of $13.8 Million Bought Deal
2017-02-09 Emerald to Participate at the 2017 MoneyShow Orlando Investor Conference
2017-02-02 Emerald Health Announces Increase in Bought Deal to $12 Million
2017-02-01 Emerald Health Announces $10 Million Bought Deal
2017-01-12 Emerald Health Files Preliminary Base Shelf Prospectus
2016-12-19 Emerald Health Therapeutics Adopts Advance Notice Policy
2016-11-29 Emerald Health Therapeutics Announces Expansion Plans
2016-11-16 Emerald Health Therapeutics Announces Completion of Private Placement
2016-11-15 Emerald Health Therapeutics Announces No Material Change
2016-10-04 Emerald Health Therapeutics Announces private placement with Sciences
2016-09-28 Emerald Health Therapeutics Announces Stock Option Grant
2016-09-22 Emerald Health Therapeutics Launches Cannabis Oils
2016-09-21 Emerald Health Therapeutics Shares for Debt Approved and Issued
2016-08-26 Emerald Health Therapeutics Announces Stock Option Grant
2016-08-08 Emerald Health announces Private Placement, Debt Conversion and Change in Directors
2016-07-12 Emerald Health Receives Sales Licence for Oils
2016-05-12 Therapeutics Completes Issues of Shares for Debt
2016-03-11 Emerald Health Announces Shares for Debt Transaction
2015-11-09 Emerald Health to begin Production of Cannabis Oil
2015-08-26 Emerald Health Therapeutics enters into Loan Agreement with Emerald Health Sciences
2015-06-19 T-Bird Pharma Inc. Announces Name Change to Emerald Health Therapeutics Inc.
2015-05-13 T-Bird Pharma Inc. Announces Funding from the Government of Canada
2015-05-07 T-Bird Pharma Inc. Announces Health Canada License Renewal including full Authorization to Sell
2015-04-24 T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences
2015-04-10 T-Bird Pharma Inc. Announces Health Canada Submission for Second Production Facility
2015-03-11 T-Bird Pharma Inc. Announces Partnership with Medna Biosciences Inc.
2015-02-10 T-Bird Pharma Inc. Announces License Renewal from Health Canada
2015-01-27 T-Bird Pharma Appoints Sandy Pratt as Chief Financial Officer
2014-12-01 T-Bird Pharma Inc. appoints Dr. Bin Huang as President, CEO and Director
2014-09-30 T-Bird Pharma Inc. Retains Pure for Investor Relations
2014-09-22 T-Bird Pharma Inc. to Increase Growing Capacity
2014-09-08 T-Bird Pharma Inc. to be British Columbia’s first Health Canada Licensed Publicly Traded Medical Marijuana Company
2014-09-05 Firebird Energy Inc. Completes Acquisition of Thunderbird Biomedical Inc.